This isn't about cherry-picking information, it's about first hand experience by actual doctors. I wouldn't personally dismiss all the clinical evidence just because it's not a controlled study, but if nothing else it should provide an incentive to do further research. The AMA don't even want to entertain the notion that further studies are warranted.
Are they actually doctors in fields that know how this medicine interacts with patients and are able to conduct double blind studies to ensure it's actually the medicine helping and not just a placebo effect? That's what I mean with them being nontransparent about the people behind them.
Double-blind studies are also preferred because the human brain is made to recognize patterns, particularly ones they expect. Hence the requirement that not even the actual physicians and doctors treating the patients during these studies know if the medicine they give the patients is the real deal or a placebo. A collection of independent physicians and surgeons is not going to be able to do those studies independently between themselves to the requirements a clinical trial needs.
It's also not the AMA's place to mandate more studies, but they're still undergoing. The AMA actually says that clinical trials are still needed before a recommendation can be made:
From:
https://www.ama-assn.org/delivering...-should-not-be-used-prevent-or-treat-covid-19
“Clinical trials and observational studies to evaluate the use of ivermectin to prevent and treat COVID-19 in humans have yielded insufficient evidence for the NIH COVID-19 Treatment Guidelines Panel to recommend its use,” the
CDC health alert explains. “Data from adequately sized, well-designed and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin in the treatment of COVID-19.”
If the AAPS wishes to conduct a clinical trial on the effects of ivermectin I'm confident they can find the people in their organization and do it properly in a coordinated effort, but just pointing at in vitro observations when there have already been preliminary clinical trials suggesting it's ineffective is just pointless and unhelpful.